The two associations are -- Chemists and Druggists Association of Baroda (CDAB) and Federation of Gujarat State Chemists and Druggists Association -- responsible for limiting and controlling the supply of drugs and medicines.
The Competition Commission of India (CCI), which has been making efforts to sensitise the public on unfair ways in the pharma industry, has also asked the two associations and their respective office bearers to cease and desist from indulging in anti-competitive practices.
Accordingly, it slapped a fine of Rs 1.08 lakh and Rs 11.11 lakh on the CDAB and the Federation of Gujarat State Chemists and Druggists Association, respectively, under the provisions of the Competition Act, 2002.
Besides, the CCI has levied a penalty of Rs 34,048 on CDAB president V T Shah and Rs 62,144 on Gujarat Federation president Jashvant Patel for their anti-competitive practices.
"Despite several orders of the Commission proscribing the anti-competitive practices of state and regional chemists and druggists associations in, inter alia, mandating NOC (No Objection Certificate) for appointment of stockists and demanding PIS (product information service) charges prior to launching of new drugs in the market, these associations are continuing to indulge in such practices," the regulator noted.
"Given the widespread and continuing indulgence in the anti-competitive practices, the Competition Commission of India will be keeping a close watch on the conduct by all such entities in various parts of the country and would not hesitate to take action, wherever deemed necessary," the ministry tweeted.
"Considering larger public interest involved in the distribution of drugs/medicines, the Competition Commission deprecates such a conduct and its perpetration in any form by those responsible, be it associations, stockists/ distributor/wholesaler/retailer and pharmaceutical companies," it added.
The Commission held CDAB responsible for mandating the requirement of NOC prior to the appointment of stockists which resulted in limiting and controlling the supply of drugs and medicines in Vadodara.
Further, the regulator said that Gujarat Federation is carrying on the practice of NOC/approval required to be taken from it prior to the appointment of a new stockist by pharmaceutical companies, resulting in limiting and controlling the supply of products/medicines in Gujarat.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
